TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Net income 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.4BFY2025 · since FY2016: $329.0M → $1.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.4B | +186.0% |
| FY2024 | -$1.6B | -193.2% |
| FY2023 | -$559.0M | +77.1% |
| FY2022 | -$2.4B | -686.6% |
| FY2021 | $417.0M | +110.5% |
| FY2020 | -$4.0B | -299.4% |
| FY2019 | -$999.0M | +53.5% |
| FY2018 | -$2.1B | +86.8% |
| FY2017 | -$16.3B | -5043.8% |
| FY2016 | $329.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice